Content about treatment for cancer

April 26, 2012
PhRMA report lists almost 300 vaccines under development

Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.

WASHINGTON — Drug makers in the United States are developing nearly 300 vaccines for preventing and treating diseases, according to a new report by a drug industry trade group.

January 10, 2011
Abstral OKed as breakthrough pain treatment for cancer patients

The Food and Drug Administration has approved a new drug for treating pain in cancer patients, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug for treating pain in cancer patients, the agency said Friday.

The FDA announced the approval of ProStrakan’s Abstral (fentanyl) transmucosal tablets for the management of pain that appears suddenly for short periods and is not alleviated by a patient’s normal pain-management plan, also known as breakthrough pain. The tablets are designed for administration on the soft surfaces of the mouth, including inside the cheek, gums and tongue, as well as the nasal passages or the throat.

December 9, 2010
Study shows 50% reduction of myeloma among patients

A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.

ANN ARBOR, Mich. — A new three-drug combination may work as a front-line treatment for cancer of the plasma cells, according to an early-stage clinical study.

October 20, 2010
Genentech's Herceptin receives FDA approval

The Food and Drug Administration has approved a biotech drug for treating cancer of the...

SOUTH SAN FRANCISCO, Calif. The Food and Drug Administration has approved a biotech drug for treating cancer of the stomach and esophageal junction.

 

Genentech, a subsidiary of Swiss drug maker Roche, announced Wednesday the approval of Herceptin (trastuzumab) as a treatment for cancer of the stomach that includes the HER2 gene and has spread to other parts of the body, when combined with chemotherapy. The drug has long since had approval as a treatment for HER2-positive breast cancer.